The estimated Net Worth of Laurent Humeau is at least $2.18 Million dollars as of 15 May 2024. Laurent Humeau owns over 4,771 units of Inovio Pharmaceuticals Inc stock worth over $170,562 and over the last 6 years he sold INO stock worth over $1,034,984. In addition, he makes $972,531 as Chief Scientific Officer at Inovio Pharmaceuticals Inc.
Laurent has made over 19 trades of the Inovio Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 4,771 units of INO stock worth $31,250 on 15 May 2024.
The largest trade he's ever made was exercising 68,811 units of Inovio Pharmaceuticals Inc stock on 26 February 2023 worth over $450,712. On average, Laurent trades about 25,545 units every 82 days since 2019. As of 15 May 2024 he still owns at least 26,040 units of Inovio Pharmaceuticals Inc stock.
You can see the complete history of Laurent Humeau stock trades at the bottom of the page.
Dr. Laurent M. Humeau Ph.D. serves as Chief Scientific Officer of the Company. Dr. Humeau has served as our Chief Scientific Officer since March 2019, having previously served as our Vice President and then Senior Vice President of Research and Development beginning in January 2014. Prior to joining us, Dr. Humeau was Senior Director of Translational Research, Human Therapeutics Division for Intrexon Corporation and previously served in a variety of roles, including Chief Scientific Officer and Vice President of Research and Development, at VIRxSYS Corporation. Dr. Humeau holds a Ph.D., summa cum laude, from Denis Diderot University (Paris 7) and a M.S. degree in Biology from Pierre & Marie Curie University (Paris 6).
As the Chief Scientific Officer of Inovio Pharmaceuticals Inc, the total compensation of Laurent Humeau at Inovio Pharmaceuticals Inc is $972,531. There are 4 executives at Inovio Pharmaceuticals Inc getting paid more, with Jong Kim having the highest compensation of $2,588,530.
Laurent Humeau is 53, he's been the Chief Scientific Officer of Inovio Pharmaceuticals Inc since 2018. There are 11 older and 3 younger executives at Inovio Pharmaceuticals Inc. The oldest executive at Inovio Pharmaceuticals Inc is Simon Benito, 75, who is the Independent Chairman of the Board.
Laurent's mailing address filed with the SEC is C/O INOVIO PHARMACEUTICALS, INC., 6769 MESA RIDGE RD., SAN DIEGO, CA, 92121.
Over the last 20 years, insiders at Inovio Pharmaceuticals Inc have traded over $23,656,819 worth of Inovio Pharmaceuticals Inc stock and bought 1,958,377 units worth $5,174,071 . The most active insiders traders include Austin W & Greenhouse David..., Jong Joseph Kim und Felix Theeuwes. On average, Inovio Pharmaceuticals Inc executives and independent directors trade stock every 22 days with the average trade being worth of $745,390. The most recent stock trade was executed by Michael John Sumner on 30 June 2024, trading 2,917 units of INO stock currently worth $19,106.
inovio is revolutionizing the fight against cancer and infectious diseases. our immunotherapies uniquely activate best-in-class immune responses to prevent and treat disease, and have shown clinically significant efficacy with a favorable safety profile. with an expanding portfolio of immune therapies, the company is advancing a growing preclinical and clinical stage product pipeline. partners and collaborators include roche, medimmune, university of pennsylvania, darpa, drexel university, nih, hiv vaccines trial network, national cancer institute, u.s. military hiv research program, and university of manitoba. for more information, visit www.inovio.com.
Inovio Pharmaceuticals Inc executives and other stock owners filed with the SEC include: